1)Bloch MH, Landeros-Weisenberger A, Rosario MC, et al:Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 165:1532-1542, 2008[PMID:18923068]
2)吉田充孝,切池信夫,永田利彦,他:強迫性障害に対するMaudsley Obsessional Compulsive lnventory(MOCI)邦訳版の有用性について.精神医学 37:291-296, 1995
3)Goodman WK, Price LH, Rasmussen SA, et al:The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46:1006-1011, 1989[PMID:2684084]
4)Goodman WK, Price LH, Rasmussen SA, et al:The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46:1012-1016, 1989[PMID:2510699]
5)Nakajima T, Nakamura M, Taga C, et al:Reliability and validity of the japanese version of the yale-brown obsessive-compulsive scale. Psychiatry Clin Neurosci 49:121-126, 1995[PMID:8726128]
6)浜垣誠司,高木俊介,漆原良和,他:自己記入式Yale-Brown強迫観念・強迫行為尺度(Y-BOCS)日本語版の作成とその検討.精神神経誌 101:152-168, 1999
7)平成27年度厚生労働省障害者対策総合研究事業「認知行動療法等の精神療法の科学的エビデンスに基づいた標準治療の開発と普及に関する研究」:不安障害の認知療法・認知行動療法マニュアル,2016
8)Foa EB, Liebowitz MR, Kozak MJ, et al:Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162:151-161, 2005[PMID:15625214]
9)豊見山泰史,中尾智博:不安症・強迫症の評価尺度の有用性と臨床活用.臨床精神医学 52:1195-1205, 2023
10)Storch EA, Rasmussen SA, Price LH, et al:Development and psychometric evaluation of the Yale-Brown obsessive-compulsive scale:Second edition. Psychol Assess 22:223-232, 2010[PMID:20528050]